Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$40.97 - $43.33 $3.26 Million - $3.44 Million
79,489 New
79,489 $3.37 Million
Q1 2023

May 15, 2023

BUY
$23.0 - $31.59 $734,482 - $1.01 Million
31,934 New
31,934 $777,000
Q3 2022

Nov 14, 2022

SELL
$28.74 - $39.9 $312,576 - $433,952
-10,876 Reduced 45.78%
12,881 $386,000
Q2 2022

Aug 15, 2022

BUY
$35.0 - $43.59 $831,495 - $1.04 Million
23,757 New
23,757 $859,000
Q3 2021

Nov 15, 2021

SELL
$62.34 - $73.38 $356,584 - $419,733
-5,720 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$70.26 - $76.64 $250,898 - $273,681
-3,571 Reduced 38.44%
5,720 $412,000
Q1 2021

May 17, 2021

BUY
$70.48 - $79.95 $654,829 - $742,815
9,291 New
9,291 $685,000
Q4 2020

Feb 16, 2021

SELL
$54.4 - $73.42 $325,910 - $439,859
-5,991 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$54.41 - $68.2 $66,108 - $82,863
1,215 Added 25.44%
5,991 $329,000
Q2 2020

Aug 14, 2020

BUY
$61.66 - $70.16 $294,488 - $335,084
4,776 New
4,776 $318,000
Q1 2020

May 14, 2020

SELL
$59.35 - $88.73 $2.96 Million - $4.42 Million
-49,833 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$74.18 - $97.92 $2.42 Million - $3.19 Million
-32,558 Reduced 39.52%
49,833 $4.38 Million
Q3 2019

Nov 14, 2019

BUY
$75.36 - $86.57 $4.16 Million - $4.77 Million
55,150 Added 202.45%
82,391 $6.22 Million
Q2 2019

Aug 15, 2019

SELL
$83.92 - $108.88 $50.4 Million - $65.5 Million
-601,142 Reduced 95.66%
27,241 $2.33 Million
Q2 2019

Aug 14, 2019

BUY
$83.92 - $108.88 $51.9 Million - $67.3 Million
618,229 Added 6088.53%
628,383 $55.3 Million
Q1 2019

May 14, 2019

SELL
$85.97 - $108.09 $576,686 - $725,067
-6,708 Reduced 39.78%
10,154 $1.1 Million
Q4 2018

Feb 14, 2019

BUY
$78.25 - $107.92 $953,554 - $1.32 Million
12,186 Added 260.61%
16,862 $1.43 Million
Q3 2018

Nov 14, 2018

SELL
$97.82 - $116.09 $4.97 Million - $5.89 Million
-50,768 Reduced 91.57%
4,676 $460,000
Q2 2018

Aug 14, 2018

SELL
$97.62 - $120.59 $4.82 Million - $5.96 Million
-49,417 Reduced 47.13%
55,444 $6.41 Million
Q1 2018

May 15, 2018

BUY
$95.91 - $107.26 $267,301 - $298,933
2,787 Added 2.73%
104,861 $10.4 Million
Q4 2017

Feb 14, 2018

BUY
$104.5 - $126.38 $10.7 Million - $12.9 Million
102,074
102,074 $10.7 Million

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.